🩹

Dermatology

42 drugs in pipeline from 10 companies

Drugs in Pipeline

Companies

Upcoming Catalysts

Phase 3 Trials

Upcoming Catalysts

Dec 2025~

LLY⭐Phase 3Phase 3

Ixekizumab Phase 3 Results Expected

Ixekizumab • Psoriasis

Jan 2026~

ANABPhase 2Phase 2

Placebo Phase 2 Results Expected

Placebo • Atopic Dermatitis

Mar 17

INCY⭐Phase 3Phase 3

Povorcitinib Phase 3 Results Expected

Povorcitinib • NonSegmental Vitiligo

View all catalysts

Pipeline by Phase

Phase 3

Phase 2

Active Companies

ARQT

Arcutis Biotherapeutics, Inc.

Astellas Pharma Inc.

Johnson & Johnson

Journey Medical Corporation

2 drugs

4151.T

Kyowa Kirin Co., Ltd.

2 drugs

VYNE

VYNE Therapeutics Inc.

5 drugs

LLY

Eli Lilly and Company

Incyte Corporation

Coherus Oncology, Inc.

2 drugs

AUPH

Aurinia Pharmaceuticals Inc.

2 drugs

Related Conditions

skindermatologypsoriasiseczemadermatitisacnewoundburnscaralopeciavitiligorosacea